CNTY-308

N/A

Report date: 2025/06/05 09:29:54

Base Information

Drug NameCNTY-308

Drug Alias NameCNTY-308

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy

Mechanisms of ActionB-lymphocyte antigen CD19 modulatorsT lymphocyte replacements

TargetsB-lymphocyte antigen CD19

Therapy Area/IndicationsAutoimmune DiseasesNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesCentury Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesCentury Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsAutoimmune DiseasesNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A